(Q50914762)

25 March 2018

title

Survival after surgical treatment for primary hyperparathyroidism (English)

1 reference

25 March 2018

1 reference

J. A. Söreide

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

J. A. van Heerden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

C. S. Grant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

C. Yau Lo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

C. Schleck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

D. M. Ilstrup

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9426427

1 December 2024

language of work or name

1 reference

1 December 1997

1 reference

25 March 2018

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9426427

full work available at URL

1 December 2024

https://api.elsevier.com/content/article/PII:S0039606097902166?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

https://api.elsevier.com/content/article/PII:S0039606097902166?httpAccept=text/plain

1 December 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

1 December 2024

1 reference

25 March 2018

volume

122

1 reference

25 March 2018

issue

1 reference

25 March 2018

page(s)

1117-1123

1 reference

25 March 2018

Surgical treatment of primary hyperparathyroidism: an institutional perspective

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Surgical therapy of patients with primary hyperparathyroidism: long-term benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Malignant neoplasms and parathyroid adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Premature death in patients operated on for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The influence of surgery on the risk of death in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Asymptomatic primary hyperparathyroidism: the case for conservative management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Psychologic symptoms before and after parathyroid surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Long-term health risk of primary hyperparathyroidism: the effect of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

Causes of death in patients previously operated on for primary hyperparathyroidism

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

Serum calcium and survival in a large health screening program

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

Primary Hyperparathyroidism: Clinicai Presentation and Factors Influencing Clinical Management

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0039-6060(97)90216-6

1 December 2024

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018